Complement 1 inhibitor is a regulator of the alternative complement pathway
about
Borrelia valaisiana resist complement-mediated killing independently of the recruitment of immune regulators and inactivation of complement componentsThe role of complement system in septic shockC1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational diseaseBIOLOGICAL ACTIVITIES OF C1 INHIBITORSERPING1 polymorphisms in polypoidal choroidal vasculopathy.Serping1/C1 Inhibitor Affects Cortical Development in a Cell Autonomous and Non-cell Autonomous Manner.Oversulfated chondroitin sulfate inhibits the complement classical pathway by potentiating C1 inhibitor.Complement blockade with a C1 esterase inhibitor in paroxysmal nocturnal hemoglobinuriaComplement in ischemia reperfusion injury.The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1qCross-talk between the complement and the kinin system in vascular permeability.Extracellular gelatinase of Enterococcus faecalis destroys a defense system in insect hemolymph and human serum.Interactions between coagulation and complement--their role in inflammationRegulation of Complement and Contact System Activation via C1 Inhibitor Potentiation and Factor XIIa Activity Modulation by Sulfated Glycans - Structure-Activity RelationshipsThe effect of C1 inhibitor on myocardial ischemia and reperfusion injury.The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema.Natural antibodies, autoantibodies and complement activation in tissue injury.C1 inhibitor: biologic activities that are independent of protease inhibition.Natural IgM-mediated innate autoimmunity: a new target for early intervention of ischemia-reperfusion injury.Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects.Inhibition of complement improves graft outcome in a pig model of kidney autotransplantation.The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.Role of complement and perspectives for intervention in ischemia-reperfusion damage.Two-dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patientsON VASCULAR STENOSIS, RESTENOSIS AND MANNOSE BINDING LECTIN.Viral-derived complement inhibitors: current status and potential role in immunomodulation.Therapeutic complement inhibition: a promising approach for treatment of neuroimmunological diseases.New insight into the effects of heparinoids on complement inhibition by C1-inhibitor.Candida albicans Shaving to Profile Human Serum Proteins on Hyphal Surface.Anti-inflammatory effects of C1-Inhibitor in porcine and human whole blood are independent of its protease inhibition activity.Complement inhibition attenuates acute kidney injury after ischemia-reperfusion and limits progression to renal fibrosis in mice.Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis.Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7.Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway.StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor.The effect of C1 inhibitor on intestinal ischemia and reperfusion injury.Refinement of tourniquet-induced peripheral ischemia/reperfusion injury in rats: comparison of 2 h vs 24 h reperfusion.Complement Dependence of Murine Costimulatory Blockade-Resistant Cellular Cardiac Allograft Rejection.Complement Activation During Ischemia/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling.Meconium Is a Potent Activator of Complement in Human Serum and in Piglets
P2860
Q21090813-6B6D7FFB-211F-4FCD-B7C7-98B0E1023CA7Q27027974-53EFD0E6-3233-41ED-A92A-558B3B2F57D6Q27644724-A95B93D6-C3BE-446C-873D-549D00DB4EA2Q28972362-F3A8303E-7AE1-434F-9B81-27A883DE3791Q33655831-C643EA83-0ECA-4CC6-8AAF-77A05814033BQ33804415-692B4D00-3D04-474A-BE0D-0652C6A3EDC9Q34450711-1E1EF498-58B6-428A-A045-DEB43F4D04ABQ34603645-7BEBE742-86AF-409E-96D3-4215A27E8D09Q35053536-7FD86EF5-C25D-4CF5-86F7-3EEC18BE60C4Q35098041-41DBD878-0BF0-4E62-8EB6-F69A28083842Q35182755-8F6264CA-112D-40FC-84C0-95435715A0B6Q35783719-BB545C46-533C-46B3-8A98-609DF2EFFAA4Q36022738-F7046587-08E9-41FA-9B27-22A108DF6E95Q36175011-A25C56B8-496C-456A-B3A0-BDF6CBF277B9Q36253316-498FB933-C82F-49AC-8E1D-AE460C9666B0Q36568742-9BB9E887-A98C-4ADD-AC00-7C93E8D6AC05Q36572982-0853E7DF-EDC8-45A6-B360-D94ED07E7F57Q36838407-FB0D5583-2136-4243-BE91-29F36A88166AQ36960513-60DE365D-2EA1-414B-8A80-084D49C42FC5Q37069747-99E2522B-520A-4843-9030-D0D5E487992DQ37280720-9FB7FDEC-DDAA-4FF9-8F8A-5E8235FB3AE3Q37644606-88E35907-1082-42D6-A5AF-5EBFC1A197D7Q37831329-AA11A166-AF1B-41A3-BC96-0CCE89E400E4Q38310999-2AEEEDC7-9AFD-4632-AA1D-361302E72916Q38819108-3A4F4ACE-33B2-4896-8CD9-B4A4BAA7EB16Q38995165-50ADA633-9871-4715-AC36-6D69CA9EFD62Q39090725-24816C0D-47D5-47C6-88C7-EA77128BB75CQ39998832-F3686433-1CD0-49EB-9E27-F87B508F8FF7Q40860112-FBFE0A2F-898C-4F4C-83DE-75903701EC14Q41393053-3513459C-FBD4-4C92-A17F-CC77723B8BEAQ41497854-0775EF18-D665-48A0-967E-237D6874106FQ41665262-FCF8B46B-018D-41EA-B2CE-1ED9E1D82D08Q42068191-E9EED6DD-39B8-4663-9F37-6B320B248936Q43697611-323A23DF-FED4-4F41-8867-78B54FC18C24Q44067982-BFCB3226-2092-42B8-BA44-8CAE2A685934Q46372780-DF1C6678-FCC0-4F61-81D4-8C6D77DDC681Q47904887-580820C6-BF9E-4D61-9736-AE2ED14A6C16Q50699634-7389B097-28B2-4AD5-8172-EC5CFE23B489Q55262251-F4514015-6995-4A40-BF15-CC72827E5B8AQ58143875-043A6F9A-6A4C-4380-9C14-CE5CFA6EDD57
P2860
Complement 1 inhibitor is a regulator of the alternative complement pathway
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Complement 1 inhibitor is a regulator of the alternative complement pathway
@ast
Complement 1 inhibitor is a regulator of the alternative complement pathway
@en
type
label
Complement 1 inhibitor is a regulator of the alternative complement pathway
@ast
Complement 1 inhibitor is a regulator of the alternative complement pathway
@en
prefLabel
Complement 1 inhibitor is a regulator of the alternative complement pathway
@ast
Complement 1 inhibitor is a regulator of the alternative complement pathway
@en
P2093
P2860
P356
P1476
Complement 1 inhibitor is a regulator of the alternative complement pathway
@en
P2093
P2860
P304
P356
10.1084/JEM.194.11.1609
P407
P577
2001-12-01T00:00:00Z